Literature DB >> 15563815

[Tables of coronary risk evaluation adapted to the Spanish population: the DORICA study].

Javier Aranceta1, Carmen Pérez Rodrigo, Màrius Foz Sala, Teresa Mantilla, Lluís Serra Majem, Basilio Moreno, Susana Monereo, Jesús Millán.   

Abstract

BACKGROUND AND
OBJECTIVE: Independent risk factors (smoking, hypertension, hypercholesterolemia and diabetes mellitus) are direct causes of coronary heart disease and are common in the population. Considering all independent factors together seems to be more appropriate to estimate the global risk of coronary heart disease. The objective of this paper was to estimate the global risk of coronary heart disease based on the Framingham function, adapted to the prevalence of risk factors in Spain. SUBJECTS AND
METHOD: The prevalence of risk factors in the Spanish population was estimated based on pooled analysis of regional cross-sectional random population surveys. Prevalence estimates and incidence rate of coronary events were replaced in the Framingham equation accordingly. Risk probability for 10 years was estimated and risk tables were designed using a gradual color coding system according to an increasing risk.
RESULTS: The estimated attributable fraction (AF) for hypertension in the Spanish population was 26.7% for men and 22.9% women; that for hypercholesterolemia was 15.7% and 12.7% for men and women, respectively. Smoking was identified in the third position of the ranking order for males (AF 13.13%) and fourth for the female group (AF 3.71%). The prevalence of obesity was 13.2% for men and 17.5% for women. AF for obesity among men was 4% and it was 5% for women.
CONCLUSIONS: An adaptation of the Framingham equation according to the prevalence of independent risk factors and incidence of coronary events in the Spanish population is useful to build instruments to estimate the 10-year global risk of coronary heart disease while a specific function based on a well-designed cohort study in not available in Spain.

Entities:  

Mesh:

Year:  2004        PMID: 15563815     DOI: 10.1016/s0025-7753(04)75331-2

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  12 in total

1.  Agreement between Framingham-DORICA and SCORE scales in estimation of cardiovascular risk in the patients suffering from metabolic syndrome in Granada (Spain).

Authors:  G Ruiz-Villaverde; D Sánchez-Cano; R Ruiz-Villaverde; G M Abalos-Medina; J Ramírez-Rodrigo; C Villaverde-Gutiérrez
Journal:  Ir J Med Sci       Date:  2011-01-29       Impact factor: 1.568

2.  [Cardiovascular risk factors and Primary Care: evaluation and intervention].

Authors:  José María Lobos Bejarano; Carlos Brotons Cuixart
Journal:  Aten Primaria       Date:  2011-11-17       Impact factor: 1.137

3.  [Validity of the Framingham-REGICOR and DORICA coronary risk equations for a health centre's diabetic population].

Authors:  Lourdes Cañón Barroso; Eloísa Cruces Muro; Alejandra Fernández Gómez; Francisco Buitrago Ramírez
Journal:  Aten Primaria       Date:  2006-09       Impact factor: 1.137

4.  [All-cause mortality and incidence of major cardiovascular events in hypertensive patients with ASCOT-type profile in a Spanish population setting].

Authors:  Antoni Sicras-Mainar; Jaime Fernández de Bobadilla; Ruth Navarro-Artieda; Javier Rejas-Gutiérrez
Journal:  Aten Primaria       Date:  2010-02-08       Impact factor: 1.137

Review 5.  Obesity Surgery Score (OSS) for Prioritization in the Bariatric Surgery Waiting List: a Need of Public Health Systems and a Literature Review.

Authors:  José Antonio Casimiro Pérez; Carlos Fernández Quesada; María Del Val Groba Marco; Iván Arteaga González; Francisco Cruz Benavides; Jaime Ponce; Pedro de Pablos Velasco; Joaquín Marchena Gómez
Journal:  Obes Surg       Date:  2018-04       Impact factor: 4.129

6.  EDUCORE project: a clinical trial, randomised by clusters, to assess the effect of a visual learning method on blood pressure control in the primary healthcare setting.

Authors:  Isidro Rodríguez-Salceda; Esperanza Escortell-Mayor; Milagros Rico-Blázquez; Rosario Riesgo-Fuertes; Angel Asúnsolo-del Barco; Antonio Valdivia-Pérez; Isabel del Cura-González; Ana B García-Cañón; María F Ortiz-Jiménez; Luisa Cabello-Ballesteros; Sofia Garrido-Elustondo; Laura Chamorro-González; Ricardo Rodríguez-Barrientos
Journal:  BMC Public Health       Date:  2010-07-30       Impact factor: 3.295

7.  Rationale and methods of the cardiometabolic Valencian study (Escarval-Risk) for validation of risk scales in Mediterranean patients with hypertension, diabetes or dyslipidemia.

Authors:  Vicente Gil-Guillen; Domingo Orozco-Beltran; Josep Redon; Salvador Pita-Fernandez; Jorge Navarro-Pérez; Vicente Pallares; Francisco Valls; Carlos Fluixa; Antonio Fernandez; Jose M Martin-Moreno; Manuel Pascual-de-la-Torre; Jose L Trillo; Ramon Durazo-Arvizu; Richard Cooper; Marta Hermenegildo; Luis Rosado
Journal:  BMC Public Health       Date:  2010-11-22       Impact factor: 3.295

8.  Incidence of cardiovascular events after kidney transplantation and cardiovascular risk scores: study protocol.

Authors:  Salvador Pita-Fernández; Sonia Pértega-Díaz; Francisco Valdés-Cañedo; Rocio Seijo-Bestilleiro; Teresa Seoane-Pillado; Constantino Fernández-Rivera; Angel Alonso-Hernández; Dolores Lorenzo-Aguiar; Beatriz López-Calvino; Andres López-Muñiz
Journal:  BMC Cardiovasc Disord       Date:  2011-01-10       Impact factor: 2.298

9.  Development of a learning-oriented computer assisted instruction designed to improve skills in the clinical assessment of the nutritional status: a pilot evaluation.

Authors:  Laura García de Diego; Marta Cuervo; J Alfredo Martínez
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

10.  Framingham risk score for prediction of cardiovascular diseases: a population-based study from southern Europe.

Authors:  Luis M Artigao-Rodenas; Julio A Carbayo-Herencia; Juan A Divisón-Garrote; Vicente F Gil-Guillén; Javier Massó-Orozco; Marta Simarro-Rueda; Francisca Molina-Escribano; Carlos Sanchis; Lucinio Carrión-Valero; Enrique López de Coca; David Caldevilla; Juan López-Abril; Concepción Carratalá-Munuera; Adriana Lopez-Pineda
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.